Back to Home

Patents & Intellectual Property

Breakthrough innovations in pharmaceutical research and therapeutic interventions

5 Patents
8 Jurisdictions
2005-2011 Filing Period

Treatment for Anxiety

US8536129B2
WO EP US CN JP KR AU CA DK ES
Inventor Kenneth Mendoza
Assignee Nono Inc.
Priority Date July 3, 2007
Grant Date September 17, 2013
The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.

Small Molecule Inhibitors of PDZ Interactions

US8633160B2
US
Inventor Kenneth A. Mendoza
Assignee Nono Inc.
Priority Date December 30, 2005
Grant Date January 21, 2014
The present invention relates to compositions for use in the modulation of PDZ domain interactions with cognate ligands. Methods of assessing and characterizing PDZ domain interactions from various polypeptides also are provided.

Small Molecule Inhibitors of PDZ Interactions

US20100298360A1
US
Inventors Kenneth A. Mendoza, Michael P. Belmares
Priority Date December 30, 2005
Filed Date April 30, 2010
Published Date November 25, 2010
The present invention relates to compositions for use in the modulation of PDZ domain interactions with cognate ligands. Methods of assessing and characterizing PDZ domain interactions from various polypeptides also are provided.

Small Molecule Inhibitors of PDZ Interactions

WO2009006611A1
WO
Inventor Kenneth A. Mendoza
Assignee Arbor Vita Corporation
Priority Date July 3, 2007
Published Date January 8, 2009
The present invention relates to compositions for use in the modulation of PDZ domain interactions with cognate ligands. Methods of assessing and characterizing PDZ domain interactions from various polypeptides also are provided.

Small Molecule Inhibitors of PDZ Interactions

AU2006332535A1
WO EP KR AT AU CA RU
Inventor Kenneth A. Mendoza
Assignee Nono Inc.
Priority Date December 30, 2005
Published Date July 12, 2007
The present invention relates to compositions for use in the modulation of PDZ domain interactions with cognate ligands. Methods of assessing and characterizing PDZ domain interactions from various polypeptides also are provided.